Clinical Trial Update: Intravitreal Celecoxib for Chronic Uveitis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravitreal celecoxib for chronic uveitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Vanderbilt University | Conditions: Inflammation | Phase 1 | Status: TERMINATED